[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100575595":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":17,"responsibleParty":29,"collaborators":7,"id":31,"slug":7,"hasResults":32,"nctId":33,"briefTitle":34,"officialTitle":34,"acronym":35,"eligibilityCriteria":36,"healthyVolunteers":32,"sex":37,"minAge":38,"maxAge":7,"enrollmentInfo":39,"targetDuration":7,"studyType":42,"phases":7,"briefSummary":43,"conditions":44,"keywords":7,"overallStatus":19,"whyStopped":7,"lastUpdateSubmitDate":49,"lastUpdatePostDateStruct":50,"startDateStruct":53,"completionDateStruct":55,"leadSponsor":57,"locationsCount":58},{"fullName":5,"class":6},"IRCCS Azienda Ospedaliero-Universitaria di Bologna","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Vincenzo Russo, MD","PRINCIPAL_INVESTIGATOR",[13],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","+390512144747","vincenzo.russo@aosp.bo.it",[18],{"facility":5,"status":19,"city":20,"state":7,"zip":21,"country":22,"cosmosGeoPoint":23,"geoPoint":28,"contacts":7},"RECRUITING","Bologna","40138","Italy",{"type":24,"coordinates":25},"Point",[26,27],11.33875,44.49381,{"lat":27,"lon":26},{"type":30,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100575595",false,"NCT06774326","Role of Spectral CT in the Evaluation of Cardiotoxicity in Patients With Hodgkin's Lymphoma and Diffuse Large B-cell Lymphoma Treated With Anthracyclines","AntraCardioTox","Inclusion Criteria:\n\n* Patients with Hodgkin's lymphoma or diffuse large B-cell lymphoma (DLBCL) undergoing treatment regimens including anthracyclines\n* Age ≥18 years\n* Informed consent obtained\n\nExclusion Criteria:\n\n* Absolute or relative contraindications to CT examination and\u002For administration of iodinated contrast agents (e.g., pregnancy, severe renal insufficiency in non-dialysis patients with GFR \\\u003C15-30 ml\u002Fmin\u002F1.73m²).\n* Patients with a concomitant positive history of cardiovascular disease (e.g., myocardial infarction, known coronary artery disease, heart failure, arrhythmias, prior myocarditis, cardiomyopathies).\n* History of mediastinal radiotherapy.","ALL","18 Years",{"count":40,"type":41},160,"ESTIMATED","OBSERVATIONAL","To evaluate the diagnostic capability of Spectral CT (performed with contrast agent as part of routine oncological follow-up) in detecting signs of acute and chronic early-onset cardiac toxicity from anthracyclines in patients with Hodgkin's lymphoma and diffuse large B-cell lymphoma undergoing treatment regimens that include a drug from this family.",[45,46,47,48],"Cardiac Imaging","Cardiac Imaging Techniques","Lymphoma","Hodgkin Disease","2025-01-09",{"date":51,"type":52},"2025-01-14","ACTUAL",{"date":54,"type":52},"2024-02-14",{"date":56,"type":41},"2029-08",{"name":5,"class":6},1]